Myovant Sciences Ltd. (MYOV)
NYSE: MYOV
· Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM
Myovant Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -183.77M | -189.59M | -165.56M | -205.98M | -228.06M | -238.46M | -283.93M | -255.13M | -238.68M | -250.44M | -253.94M |
Depreciation & Amortization | 3.25M | 3.14M | 3.14M | 3.07M | 3M | 2.87M | 2.65M | 2.48M | 2.32M | 2.19M | 1.96M |
Stock-Based Compensation | 41M | 37.23M | 37.37M | 38.93M | 62.25M | 62.06M | 57.13M | 53.68M | 27.82M | 40.6M | 41.61M |
Other Working Capital | -86.79M | -75.46M | -73.3M | -76.69M | -81.33M | 595.15M | 559.39M | 582.15M | 663.56M | 16.12M | -2.4M |
Other Non-Cash Items | 1.16M | 1.78M | 2.39M | 2.42M | 2.42M | -3.9M | -10.93M | -15M | -16.41M | -6.26M | 1.04M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -131.51M | -111.43M | -108.73M | -107M | -101.04M | 582.05M | 554.52M | 584.61M | 669.3M | 17.31M | -7.01M |
Operating Cash Flow | -269.87M | -258.87M | -231.39M | -268.56M | -261.42M | 404.63M | 319.44M | 370.63M | 444.34M | -196.6M | -216.34M |
Capital Expenditures | -865K | -999K | -1.05M | -974K | -1.46M | -1.4M | -1.62M | -1.77M | -1.31M | -1.3M | -1.11M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -24.77M | -48.95M | -50.49M | -118.75M | -135.1M | -129.4M | -127.28M | -63.82M | -47.56M | -33.79M | -19.89M |
Sales Maturities Of Investments | 70.95M | 117.47M | 102.17M | 101.7M | 97.4M | 48.64M | 57.42M | 56.39M | 31.04M | 27.59M | 15.8M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.44M | -10.72M |
Investing Cash Flow | 45.31M | 67.52M | 50.63M | -18.02M | -39.16M | -82.16M | -71.48M | -9.21M | -17.84M | 8.93M | -15.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.48M | 15.91M | 22.96M | 25.91M | 51.9M | 109.6M | 159.99M | 238.04M | 205.56M | 152.12M | 90.51M |
Financial Cash Flow | 13.48M | 15.91M | 22.96M | 25.91M | 51.9M | 109.6M | 159.99M | 238.04M | 205.56M | 152.12M | 90.51M |
Net Cash Flow | -211.08M | -175.44M | -157.8M | -260.68M | -248.67M | 432.07M | 407.95M | 599.46M | 632.06M | -35.55M | -141.76M |
Free Cash Flow | -270.73M | -259.87M | -232.43M | -269.53M | -262.88M | 403.23M | 317.81M | 368.86M | 443.03M | -197.9M | -217.46M |